Literature DB >> 28489314

Unclassifiable pattern of hypopigmentation in a patient with mosaic partial 12p tetrasomy without Pallister-Killian syndrome.

Viola Alesi1, Maria L Dentici1, Fabrizia Restaldi1, Valeria Orlando1, Maria T Liambo1, Chiara Calacci1, Rossella Capolino1, Maria C Digilio1, May El Hachem2, Antonio Novelli1, Andrea Diociaiuti2, Bruno Dallapiccola1.   

Abstract

Pallister-Killian syndrome (PKS-#OMIM601803) is a multisystem developmental disorder typically due to the presence of an aneuploidy cell line, consisting of a supernumerary tetrasomic chromosomal marker (SCM) arisen from the short arm of chromosome 12 (12p isochromosome). The clinical phenotype, which is strictly related to the percentage and tissue distribution of aneuploid cells, is characterized by craniofacial dysmorphisms, pigmentary skin anomalies, limb shortening, congenital heart defects, diaphragmatic hernia, hypotonia, intellectual disability, and epilepsy. We report on a 4 year-old girl harboring a 12p partial isochromosome, involving the PKS critical region, affecting about 70% of circulating lymphocytes, urine, and saliva cells and fibroblast from a hyperpigmented skin spot, and 100% of fibroblasts from a hypopigmented skin spot. Interestingly, despite the high proportion of affected cells this patient did not present with PKS, and a pattern of linear and patchy pigmentary mosaicism was the sole clinical manifestation. The present observation suggests that partial 12p SCM can also result in mild phenotypes, and its prevalence in the human population could have been underestimated. Accurate dermatologic evaluation could be a major handle for genetic testing.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  12p isochromosome; 12p13.3; Pallister-Killian; hypopigmentation; skin dyschromia

Year:  2017        PMID: 28489314     DOI: 10.1002/ajmg.a.38269

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  2 in total

1.  A high level of tetrasomy 9p mosaicism but no clinical manifestations other than moderate oligozoospermia with chromosomally balanced sperm: a case report.

Authors:  Hela Bellil; Bérenice Herve; Elodie Herzog; Jean-Marc Ayoubi; François Vialard; Marine Poulain
Journal:  J Assist Reprod Genet       Date:  2020-01-24       Impact factor: 3.412

2.  Chromosomal mosaicism detected by karyotyping and chromosomal microarray analysis in prenatal diagnosis.

Authors:  Yi Zhang; Mei Zhong; Dezhong Zheng
Journal:  J Cell Mol Med       Date:  2020-11-17       Impact factor: 5.310

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.